Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors

Authors

Keywords

Journal

Volume 4, Issue 2, Pages 112-117

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2009-05-22

DOI

10.1097/coh.0b013e328322f95e

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now